EAH.LSE

Eco Animal Health Group Plc

EAH.LSE, UK

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.

https://ecoanimalhealth.com

Stock Price

GBp 0.00

0%

decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
EAH.LSE
stock
EAH.LSE

Best LSE share chat forums to discuss stocks in 2025 Good Money Guide

Read more →
EAH.LSE
stock
EAH.LSE

Londonitis: Beazley and Hiscox should look hard at their London listings Insurance Insider

Read more →

Showing 2 of 6

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

$

Analyst Picks

Strong Buy

0

Buy

4

Hold

0

Sell

0

Strong Sell

0

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

High

25.50

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very High

81.67

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-0.43 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-0.32 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-2.76 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very High

0.25

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 0.00% of the total shares of Eco Animal Health Group Plc

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

-0.0054

EPS Estimate

—

EPS Difference

0

Surprise Percent

0%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(5.3)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(1.5)
Momentum
Moderate Momentum(6)
Net Net
Not Undervalued (Net-Net)(3)
Quality
Moderate Quality(4)
Value
Fair Value(3.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

ÂŁ 0

Cost Of Revenue

ÂŁ 0

Gross Profit

ÂŁ 0

Operating Expenses

ÂŁ 0

Operating Income

ÂŁ 0

Interest Expense

ÂŁ 0

Pretax Income

ÂŁ 0

Net Income

ÂŁ 0

Income Tax Expense

ÂŁ 0

EBITDA

ÂŁ 0

Total Other Income Expense Net

ÂŁ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

ÂŁ 0

Short Term Investments

ÂŁ 0

Receivables

ÂŁ 0

Inventories

ÂŁ 0

Total Current Assets

ÂŁ 0

Property Plant Equipment

ÂŁ 0

Total Assets

ÂŁ 0

Payables

ÂŁ 0

Short Term Debt

ÂŁ 0

Long Term Debt

ÂŁ 0

Total Liabilities

ÂŁ 0

Equity

ÂŁ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

ÂŁ 0

Depreciation

ÂŁ 0

Change In Working Capital

ÂŁ 0

Cash From Operations

ÂŁ 0

Capital Expenditures

ÂŁ 0

Cash From Investing

ÂŁ 0

Cash From Financing

ÂŁ 0

Net Change In Cash

ÂŁ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.